Investor's Alert on: Nuvilex Inc (OTCMKTS:NVLX), Softbank Corp. (Japan … – Techsonian (press release)

Chicago, IL, April 17, 2014 — (Techsonian) – Nuvilex Inc (OTCMKTS:NVLX) a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, reported that it has contracted Clinical Network Services Pty Ltd, a fully integrated drug development company based in Australia, New Zealand and the United Kingdom, to handle every aspect of Nuvilex’s late-phase clinical trials in pancreatic cancer as Nuvilex’s Contract Research Organization.

Nuvilex Inc (OTCMKTS:NVLX) closed latest trading day at $0.275, down -11.29%, on volume of over 8.28 million shares. The stock fell -26.08% in the last 5 days. Its average trading volume is 8.96 million shares. In the time frame of the last one month, the share-price has plunged almost -29.67%. Its market capitalization was $175.53 million.

Has NVLX Found The Bottom and Ready To Move Up? Find Out Here

Softbank Corp. (Japan) (OTCMKTS:SFTBY), works in the information industry in Japan. It operates through four segments: Mobile Communications, Fixed-line Telecommunications, Broadband Infrastructure, and Internet Culture. The Mobile Communications section offers mobile communications services, as well as offers content; and sells mobile phone handsets, such as iPhones, iPads, and SoftBank smart phones.

Shares of Softbank Corp. (Japan) (OTCMKTS:SFTBY) traded in a range of $37.30 to $38.10, completing the day up +9.26% to $37.86. The total volume of shares exchanged was 815,066.00. The day started out with an opening price of $37.30. Its market capitalization is now about $83.21 billion.

For How Long SFTBY’s Gloss will Attract Investors ? Find out via this report

Creative Edge Nutrition Inc (OTCMKTS:FITX) CEN Biotech reported that it has engaged Push Point Management Group, to offer strategic corporate consulting and capital markets support to CEN Biotech’s management team. Under the scope of services, PPMG will implement a unique set of strategic initiatives that will be focused on generating shareholder value.

Creative Edge Nutrition Inc (OTCMKTS:FITX) finished last trade at $0.0636, gaining +6.18%. Trading volume recorded for this company was about 39.93 million shares as compared to its average volume of 55.99 million shares. The share price plunged almost -20.4% in the last one month while its 52 week high is $0.11. The company has the total of 3.42 billion outstanding shares while its market capitalization is now about $217.35 million.

Will FITX Continue To Move Higher? Find Out Here

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. Company specializing in cannabis formulation-based drug development and related consulting is reported plans to enter the State of Nevada where new law expands medical cannabis opportunities to research, grows, and dispensaries.

Cannabis Science Inc (OTCMKTS:CBIS) traded with +26.14% gain to $0.111 in the latest trading session It captured $84.51 million in market value. The total number of shares traded on the latest trading day was about 11.30 million shares. The day started out with an opening price of $0.09 and changed hands at price range of $0.09 to $0.11 apiece.

Why Should Investors Buy CBIS After The Recent Gain? Just Go Here and Find Out

This entry passed through the Full-Text RSS service — if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.